Current views on the possible involvement of aluminum in the etiology of Alzheimer's disease

Abstract

The aim of the study was to investigate the possibility of using а concentration of aluminum as a marker of neurodegenerative diseases.Material and methods. To achieve this goal, there was carried out an analysis of literary origins from various databases, in particular Scopus and PubMed.Results. The analysis shows that by now there has been accumulated strong evidence that certain neurodegenerative diseases are associated with chronic exposure to low-dose of aluminum: in particular, Alzheimer's disease (AD); motor neuron disease or amyotrophic lateral sclerosis (ALS); multiple sclerosis (MS) and a number of others.Conclusion. Thus, it can be assumed that the measurement of the concentration of Al in the blood plasma will make it possible to identify a group people with of high risk of AD, which will allow starting preventive treatment at the earliest stage of the disease. The capabilities of the existing methods of analysis: atomic absorption spectrometry with electrothermal atomization (GFAAS) and inductively coupled plasma mass spectrometry (ICP-MS) enable to solve this problem.